Stay updated on Pembrolizumab in Advanced Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. No study content or user-facing functionality appears to be affected.
    Difference
    0.0%
    Check dated 2026-01-14T01:50:23.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now includes a new Revision: v3.3.3 and removes HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer, which are maintenance/versioning updates rather than trial data changes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T17:29:01.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    Publication source text was clarified to state that publications are automatically filled from PubMed and may not be about the study, and the Revision label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T18:21:38.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Removed the government funding and NIH operating status notice from the page. The core study details, eligibility criteria, and trial information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T17:59:48.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    The screenshots show the same study page with only minor formatting/layout adjustments and no changes to core details such as the study title, identifiers, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T12:38:38.000Z thumbnail image
  8. Check
    110 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice with operating status guidance and a link to cc.nih.gov and opm.gov. - Updated version from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-05T17:18:48.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Advanced Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Gastric Cancer Clinical Trial page.